Baseline cardiovascular magnetic resonance findings for the study cohort
| No fibrosis | Fibrosis | All patients | p Value | |
|---|---|---|---|---|
| CMR parameters—n (%) | 240 (33.8) | 471 (66.2) | 711 | |
| Maximum end-diastolic LV wall thickness—mm | 16.6±3.7 | 20.8±5.2 | 19.4±5.1 | <0.001 |
| LV-EDV index—mL/m2 | 67.8±14.5 | 69.8±16.2 | 69.1±15.7 | 0.123 |
| LV-ESV index—mL/m2 | 15.9±7.5 | 19.3±10.3 | 18.2±9.6 | <0.001 |
| LV EF—% | 77.1±7.3 | 73.3±9.5 | 74.6±9.0 | <0.001 |
| <50% | 1 (0.4) | 11 (2.3) | 12 (1.7) | 0.021 |
| 50–59% | 5 (2.1) | 25 (5.3) | 30 (4.2) | |
| ≥60% | 232 (97.5) | 434 (92.3) | 666 (94.1) | |
| LV mass index—g/m2 | 88.7±25.1 | 108.4±40.1 | 101.9±37.0 | <0.001 |
| Extent of LGE—% of LV mass | – | 9.5 (9.9) | 6.3 (9.2) | – |
| Median—% of LV Mass (IQR) | – | 5.9 (2.2, 13.3) | 2.2 (0, 9.1) | – |
All values are mean±SD unless otherwise stated.
CMR, cardiovascular magnetic resonance; EDV, end-diastolic volume; ESV, end-systolic volume; LGE, late gadolinium enhancement.